You are here

Article Text

Article menu
Download PDFPDF
PostScript
Correspondence
Dynamic expiratory airway collapse and evaluation of collateral ventilation with Chartis
  1. Pallav L Shah1,2,3,
  2. Felix J F Herth4,5
  1. 1 The NIHR Respiratory Biomedical Research Unit at Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UK
  2. 2 Chelsea & Westminster Hospital, London, UK
  3. 3 National Heart & Lung Institute, Imperial College, London, UK
  4. 4 Pneumology and Respiratory Care Medicine, Thoraxklinik, University of Heidelberg, Heidelberg, Germany
  5. 5 Translational Lung Research Center, Heidelberg, Germany
  1. Correspondence to Dr Pallav L Shah, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK; pallav.shah@ic.ac.uk

https://doi.org/10.1136/thoraxjnl-2013-204875

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We thank Gesierich et al 1 for raising some important issues regarding the evaluation of collateral ventilation using the Chartis flow catheter. In our review, we only provided two classical examples of Chartis expiratory flow and inspiratory pressure results; one from a patient with no collateral ventilation and another from a patient with significant collateral ventilation.2 However, in clinical practice, a range of findings are observed that sit in the ‘grey zone’.

In our practice and the results from an open-label multicentre study of valves where collateral ventilation was assessed with the Chartis system, it is evident that adequate assessment was not possible in about 15% of patients.3 A variety of factors may be responsible. Blockage of the catheter by secretions or apposition of the catheter against …

View Full Text

Footnotes

  • Contributors PLS and FJFH equally contributed to this letter.

  • Competing interests PLS and FJFH have participated in clinical trials on endobronchial valves and the Chartis system and the host institutions have been reimbursed for some clinical trial expenses by Pulmonx.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles